Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia

Chun Seok Cho, Gregory J. Kato, Seung Ha Yang, Sung Won Bae, Jong Seo Lee, Mark T. Gladwin, Sue Goo Rhee

Research output: Contribution to journalArticle

Abstract

Chronic redox imbalance in erythrocytes of individuals with sickle cell disease (SCD) contributes to oxidative stress and likely underlies common etiologies of hemolysis. We measured the amounts of six antioxidant enzymes-SOD1, catalase, glutathione peroxidase 1 (GPx1), as well as peroxiredoxins (Prxs) I, II, and VI-in red blood cells (RBCs) of SCD patients and control subjects. The amounts of SOD1 and Prx VI were reduced by about 17% and 20%, respectively, in SCD RBCs compared with control cells. The amounts of Prx II and GPx1 did not differ between SCD and normal RBCs. However, about 18% of Prx II was inactivated in SCD RBCs as a result of oxidation to sulfinic Prx II, whereas inactive Prx II was virtually undetectable in control cells. Furthermore, GPx1 activity was reduced by about 33% in SCD RBCs, and the loss of activity was correlated with hemolysis in SCD patients. RBCs from SCD patients taking hydroxyurea demonstrated 90% higher GPx1 activity than did those from untreated SCD patients, with no differences seen for the other catalytic antioxidants. Hydroxyurea induced GPx1 expression in multiple cultured cell lines in a manner dependent on both p53 and NO-cGMP signaling pathways. GPx1 expression represents a previously unrecognized potential benefit of hydroxyurea treatment in SCD patients.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalAntioxidants and Redox Signaling
Volume13
Issue number1
DOIs
StatePublished - Jul 1 2010
Externally publishedYes

Fingerprint

Hydroxyurea
Sickle Cell Anemia
Blood
Erythrocytes
Cells
Hemolysis
Antioxidants
glutathione peroxidase GPX1
Peroxiredoxins
Oxidative stress
Catalase
Oxidation-Reduction
Cultured Cells
Oxidative Stress
Cell Line
Oxidation

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology
  • Physiology
  • Clinical Biochemistry

Cite this

Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia. / Cho, Chun Seok; Kato, Gregory J.; Yang, Seung Ha; Bae, Sung Won; Lee, Jong Seo; Gladwin, Mark T.; Rhee, Sue Goo.

In: Antioxidants and Redox Signaling, Vol. 13, No. 1, 01.07.2010, p. 1-11.

Research output: Contribution to journalArticle

Cho, Chun Seok ; Kato, Gregory J. ; Yang, Seung Ha ; Bae, Sung Won ; Lee, Jong Seo ; Gladwin, Mark T. ; Rhee, Sue Goo. / Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia. In: Antioxidants and Redox Signaling. 2010 ; Vol. 13, No. 1. pp. 1-11.
@article{89f12fe8053646fc8fe087d45757fc61,
title = "Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia",
abstract = "Chronic redox imbalance in erythrocytes of individuals with sickle cell disease (SCD) contributes to oxidative stress and likely underlies common etiologies of hemolysis. We measured the amounts of six antioxidant enzymes-SOD1, catalase, glutathione peroxidase 1 (GPx1), as well as peroxiredoxins (Prxs) I, II, and VI-in red blood cells (RBCs) of SCD patients and control subjects. The amounts of SOD1 and Prx VI were reduced by about 17{\%} and 20{\%}, respectively, in SCD RBCs compared with control cells. The amounts of Prx II and GPx1 did not differ between SCD and normal RBCs. However, about 18{\%} of Prx II was inactivated in SCD RBCs as a result of oxidation to sulfinic Prx II, whereas inactive Prx II was virtually undetectable in control cells. Furthermore, GPx1 activity was reduced by about 33{\%} in SCD RBCs, and the loss of activity was correlated with hemolysis in SCD patients. RBCs from SCD patients taking hydroxyurea demonstrated 90{\%} higher GPx1 activity than did those from untreated SCD patients, with no differences seen for the other catalytic antioxidants. Hydroxyurea induced GPx1 expression in multiple cultured cell lines in a manner dependent on both p53 and NO-cGMP signaling pathways. GPx1 expression represents a previously unrecognized potential benefit of hydroxyurea treatment in SCD patients.",
author = "Cho, {Chun Seok} and Kato, {Gregory J.} and Yang, {Seung Ha} and Bae, {Sung Won} and Lee, {Jong Seo} and Gladwin, {Mark T.} and Rhee, {Sue Goo}",
year = "2010",
month = "7",
day = "1",
doi = "10.1089/ars.2009.2978",
language = "English (US)",
volume = "13",
pages = "1--11",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia

AU - Cho, Chun Seok

AU - Kato, Gregory J.

AU - Yang, Seung Ha

AU - Bae, Sung Won

AU - Lee, Jong Seo

AU - Gladwin, Mark T.

AU - Rhee, Sue Goo

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Chronic redox imbalance in erythrocytes of individuals with sickle cell disease (SCD) contributes to oxidative stress and likely underlies common etiologies of hemolysis. We measured the amounts of six antioxidant enzymes-SOD1, catalase, glutathione peroxidase 1 (GPx1), as well as peroxiredoxins (Prxs) I, II, and VI-in red blood cells (RBCs) of SCD patients and control subjects. The amounts of SOD1 and Prx VI were reduced by about 17% and 20%, respectively, in SCD RBCs compared with control cells. The amounts of Prx II and GPx1 did not differ between SCD and normal RBCs. However, about 18% of Prx II was inactivated in SCD RBCs as a result of oxidation to sulfinic Prx II, whereas inactive Prx II was virtually undetectable in control cells. Furthermore, GPx1 activity was reduced by about 33% in SCD RBCs, and the loss of activity was correlated with hemolysis in SCD patients. RBCs from SCD patients taking hydroxyurea demonstrated 90% higher GPx1 activity than did those from untreated SCD patients, with no differences seen for the other catalytic antioxidants. Hydroxyurea induced GPx1 expression in multiple cultured cell lines in a manner dependent on both p53 and NO-cGMP signaling pathways. GPx1 expression represents a previously unrecognized potential benefit of hydroxyurea treatment in SCD patients.

AB - Chronic redox imbalance in erythrocytes of individuals with sickle cell disease (SCD) contributes to oxidative stress and likely underlies common etiologies of hemolysis. We measured the amounts of six antioxidant enzymes-SOD1, catalase, glutathione peroxidase 1 (GPx1), as well as peroxiredoxins (Prxs) I, II, and VI-in red blood cells (RBCs) of SCD patients and control subjects. The amounts of SOD1 and Prx VI were reduced by about 17% and 20%, respectively, in SCD RBCs compared with control cells. The amounts of Prx II and GPx1 did not differ between SCD and normal RBCs. However, about 18% of Prx II was inactivated in SCD RBCs as a result of oxidation to sulfinic Prx II, whereas inactive Prx II was virtually undetectable in control cells. Furthermore, GPx1 activity was reduced by about 33% in SCD RBCs, and the loss of activity was correlated with hemolysis in SCD patients. RBCs from SCD patients taking hydroxyurea demonstrated 90% higher GPx1 activity than did those from untreated SCD patients, with no differences seen for the other catalytic antioxidants. Hydroxyurea induced GPx1 expression in multiple cultured cell lines in a manner dependent on both p53 and NO-cGMP signaling pathways. GPx1 expression represents a previously unrecognized potential benefit of hydroxyurea treatment in SCD patients.

UR - http://www.scopus.com/inward/record.url?scp=77953004335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953004335&partnerID=8YFLogxK

U2 - 10.1089/ars.2009.2978

DO - 10.1089/ars.2009.2978

M3 - Article

C2 - 19951064

AN - SCOPUS:77953004335

VL - 13

SP - 1

EP - 11

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 1

ER -